Cap.org v. 1 Gynecologic Consensus Conference Topic Group 3: GYN Workload Limits June 4, 2011.

Slides:



Advertisements
Similar presentations
Comprehensive Clinical Management Program
Advertisements

Standardizing Methods of Calculating and Reporting CT Dose.
The Impact of Gynecologic Pathology Diagnostic Errors on Patient Care Dana Marie Grzybicki MD, PhD Colleen M. Vrbin, BA Danielle Pirain, BS Stephen S.
Overview of IS Controls, Auditing, and Security Fall 2005.
The Effect of Lecture and a Standardized Patient Encounter on Medical Student Rape Myth Acceptance and Attitudes Toward Screening Patients for a History.
MANAGEMENT OF THE ABNORMAL PAP SMEAR
Module 6 “Normal Values”: How are Normal Reference Ranges Established?
Breast Density A patient guide.
Cap.org v. 1 Gynecologic Consensus Conference Working Group 3, Topic 6: General Quality June 4, 2011.
Brenda Chriss, Kim DeLaughder Chris diMuro, Julie Fritz-Rubert August 7, 2014 INTRODUCTION TO STEP-PLUS College of Agricultural & Environmental Sciences.
COLPOSCOPY RANDOM CERVICAL BIOPSIES ENDOCERVICAL CURETTAGE S.C.P.M.G.-Fontana.
Hand-out associated with part I of the January Workload Webinar “Workload Issues for Computer-Aided Cytology Devices” ASCT Educational Webinar January.
Integrated Planning & Budget Survey June 15, 2011.
R U There? Looking for those Teaching Moments in Chat Transcripts Frances Devlin, John Stratton and Lea Currie University of Kansas ALA Annual Conference.
Management of Women with CIN 1 or LSIL
Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening Obstetrics and Gynecology, Volume 103,
1 Historical overview of FDA regulation of digital pathology imaging applications: the safety and effectiveness issues Tremel A. Faison, MS, RAC, SCT(ASCP)
Update on Colorectal Cancer Screening Tests Source: Levin Bernard et al. Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous.
Christine Noga Booth, MD Cytopathology Fellowship Program Director
CERVICAL SCREENING WITH LUVIVA MACHINE FOR EARLY DETECTION OF CERVICAL DYSPLASIA: EXPERIENCE FROM EKITI STATE, NIGERIA Sunday O. Omoya, Abimbola M. Obimakinde.
Review of the Guidelines for Cervical Screening in New Zealand Presentation for smear-takers September 2008.
CHEN Program Assessment Advisory Board Meeting June 3 rd, 2012.
Prevention and Early Detection of Breast Cancer: Weighing the Risks and Benefits Kathy J. Helzlsouer, M.D., M.H.S. Prevention and Research Center, Women’s.
SoftPAP® A Novel Collection Device for Cervical Cytology.
The Audit Process Tahera Chaudry March Clinical audit A quality improvement process that seeks to improve patient care and outcomes through systematic.
1 Module ON-SITE SUPERVISION OVERVIEW. 2 Content Overview What is on-site supervision? Advantages and disadvantages of on-site supervision Organization.
Role of Biomarkers in Management of Prostate Cancer Dr. Angela Amayo Specialist Pathologist 13 th April 2012.
The New Studies of Religion Syllabus Implementation Package: Session Two.
Hot Topics Clinical Medicine ACHA Annual Meeting Boston, MA May 31, 2013.
Monitoring, supervision and quality control IDSP training module for state and district surveillance officers Module 11.
Automated CBC Parameters
بسم الله الرحمن الرحيم.
Cap.org v. 1 Gynecologic Cytopathology Quality Consensus Conference Working Group 4: Cytologic-Histologic Correlations June 4, 2011.
Report from Cervical Cancer Committee Maryland State Cancer Plan Strategies for Improving the Control of Cervical Cancer in Maryland.
GOVERNOR’S EARLY CHILDHOOD ADVISORY COUNCIL (ECAC) September 9, 2014.
Destination Nutrition The Calorie Count Process. Importance of Adequate Calories and Protein The body needs adequate calories and protein to supply the.
Cap.org v. 1 Gynecologic Consensus Conference Working Group 1: Monitoring Interpretive Rates, Concordance of Interpretations, Turnaround Time June 4, 2011.
HW215: Models of Health & Wellness Unit 7: Health and Wellness Models Geo-political Influences.
Presented by CIDA on behalf of the Task Team on Multilateral Effectiveness.
DEVELOPING PARENT INVOLVEMENT POLICIES Title I No Child Left Behind (NCLB) Section 1118.
Cap.org v. 1 Gynecologic Consensus Conference Working Group 2: Prospective and Retrospective Review June 4, 2011.
Cap.org v. 1 Gynecologic Consensus Conference Work Group 3: PAP Proficiency Testing, General Quality Practices, and Workload June 4, 2011.
Environmental Systems and Society Internal Assessment.
Screening of genital cancers Evidence Based Presented by Dr\ Heba Nour.
United States Department of Agriculture Food Safety and Inspection Service Overview of Trim Sampling Compliance Guidelines and Discussion Daniel Engeljohn,
Development of Toxicity Indicators Steven Bay Southern California Coastal Water Research Project (SCCWRP)
12/10/02Sacks - Clinical Assessment1 Clinical Assessment – Part II William Sacks, PhD, MD Clinical Assessment – Part II William Sacks, PhD, MD COMPUTERIZED.
Patient Safety Monitoring in International Laboratories (SMILE) Mark Swartz, MT(ASCP), SMILE QA/QC Coordinator Improving the Sensitivity of QC Monitoring:
Results of the HTA Adequacy Study JHF Smith Royal Hallamshire Hospital, Sheffield BAC Scientific Meeting 2013.
PUTTING PREVENTION FIRST Vascular Checks/ NHS Health Checks.
PSA screening Cost Conscious Project Kristopher Huston January 2016.
Date of download: 6/21/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Cervical Cancer Screening With Both Human Papillomavirus.
Abstract  An abstract is a concise summary of a larger project (a thesis, research report, performance, service project, etc.) that concisely describes.
Morphologic Pap Test Findings in HPV Negative Women Age 30 Years and Older: What Information Will Be Lost with HPV Only Primary Screening? Brooke Henninger,
Introduction to Quality Assurance. Quality assurance vs. Quality control.
From: Screening for Syphilis Infection in Pregnancy: U. S
Public Health England leads the NHS Screening Programmes
Performance of mRNA- and DNA-based high-risk human papillomavirus assays in detection of high-grade cervical lesions ELINA VIRTANEN1, ILKKA KALLIALA2,3,
Quality issues in monitoring diagnostic and treatment performance Dr
Chapter 33 Introduction to the Nursing Process
Colorectal Cancer Screening Guidelines
From: Inefficiencies and High-Value Improvements in U. S
From: Use of Decision Models in the Development of Evidence-Based Clinical Preventive Services Recommendations: Methods of the U.S. Preventive Services.
Internal assessment criteria
Ontario Colposcopy Clinical Guidance 2016
Diabetes Self-Management Education and Support: Component of Standard Diabetes Care 1, 2 “… Ongoing patient self-management education and support are.
کنترل کيفی در سيتولوژی سرويکوواژينال
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Public Health England leads the NHS Screening Programmes
Presentation transcript:

cap.org v. 1 Gynecologic Consensus Conference Topic Group 3: GYN Workload Limits June 4, 2011

Although the issue of workload was not included in the original survey questions, this workgroup recognizes that workload is an area of cytology laboratory quality that warrants further discussion. Evaluation of individual workload assessments, as well as laboratory daily screening limits, have been questioned. Background © 2011 College of American Pathologists. All rights reserved. 2

Workload Limits mandated by CLIA were established to prevent excessive workloads, which could decrease sensitivity and result in false negative results. Current literature suggests that workload limits should be reevaluated, based on daily screening sensitivity and laboratory abnormal rates. Background © 2011 College of American Pathologists. All rights reserved. 3

The American Society of Cytopathology (ASC) Productivity and Quality Assurance in the Era of Automated Screening Task Force has compiled preliminary recommendations for imaged guided screening workloads This committee is presenting for discussion: o A summary of the ASC preliminary recommendations for automated screening o Items for consideration for manual (non-imaged guided) screening Background © 2011 College of American Pathologists. All rights reserved. 4

Cytotechnologists’ screening time should not exceed 7 hours in an 8-hour work shift, provided there are no additional duties or distractions, and should not exceed 7 hours in a 24 hour day. o Based on the ARTISTIC Trial and other literature indicating sensitivity decreases below 95% after 5 hours of screening in a work day. o In comparison, US studies show a sensitivity of 80-85% when screening for an entire work day. Kitchener HC, et al. Lancet Oncol2009 Jul;10(7): Ellis K, et al. Diagn Cytopathol 2010 Nov 2. Wilbur DC, et al. Am J Clin Pathol2009 Nov;132(5): Biscotti CV, et al. Am J Clin Pathol2005;123: Discussion: Preliminary ASC Recommendation #1 © 2011 College of American Pathologists. All rights reserved. 5

Recommendation #1: Cytotechnologists’ screening time should not exceed 7 hours in an 8-hour work shift, provided there are no additional duties or distractions, and should not exceed 7 hours in a 24 hour day. 61.Do you agree with recommendation #1? A.Yes86.67% B.No11.67% C.Other1.67% Voting © 2011 College of American Pathologists. All rights reserved. 6

Workload limits should not be extrapolated to 8 hrs of screening, rather it should take into account screening time plus necessary mini breaks. o Workload limits set for the FDA TIS trial and BD FocalPoint GS were based on extrapolated data o Literature suggests that these limits are too high and sensitivity decreases after 4 hours for most cytotechnologists ThinPrep Imaging System. Package Insert Becton Dickinson Co. BD FocalPoint GS Imaging System Package Insert. Biscotti CV, et al. Am J Clin Pathol2005;123:281-7 Elsheikh T, et al. Cancer Cytopathol2010;118:75-82 Discussion: Preliminary ASC Recommendation #2 © 2011 College of American Pathologists. All rights reserved. 7

Recommendation #2: Workload limits should not be extrapolated to 8 hrs of screening, rather it should take into account screening time plus necessary mini breaks. 62.Do you agree with recommendation #2? A.Yes96.67% B.No3.33% Voting © 2011 College of American Pathologists. All rights reserved. 8

Although the False Negative Rate (FNR) is not an ideal measurement, it should be calculated at the ASCUS (not LSIL) threshold, if utilized by the laboratory. o No studies have used the FNR as a successful primary measure of screening sensitivity. o Rare studies show the results of FNR calculated at the threshold of ASCUS correlate with other measures associated with sensitivity. o Performance of screening for LSIL may not be a good surrogate for screening of other more significant lesions Elsheikh T, et al. Cancer Cytopathol2010;118:75-82 Renshaw AA, et al. Arch Pathol Lab Med2006;130: Renshaw AA, et al. Arch Pathol Lab Med2005;129: Renshaw AA,et al. Arch Pathol Lab Med2006;130: Renshaw AA, et al. Arch Pathol Lab Med2005;129:23-5 Discussion: Preliminary ASC Recommendation #3 © 2011 College of American Pathologists. All rights reserved. 9

Recommendation #3: Although the False Negative Rate (FNR) is not an ideal measurement, it should be calculated at the ASCUS (not LSIL) threshold, if utilized by the laboratory. 63.Do you agree with recommendation #3? A.Yes68.52% B.No22.22% C.Other9.26% Voting © 2011 College of American Pathologists. All rights reserved. 10

The average laboratory cytotechnologist productivity should not exceed: 80 slides/day using the new FDA/CLIA/CAP recommendations for calculating workload (imaged slide only = 0.5 slide, full manual review = 1.0 slide, imaged + manual review = 1.5 slide) Or 100 slides/day, where all examined slides (imaged or not) are counted as 1.0 slides o Studies that document the move from manual to automated screening show a consistent increase in ECA sensitivity when workload is restricted to these values, and a consistent decrease in ECA sensitivity when workload exceeds these limits. o Studies examining ECA rate when cytotechnologists increase their workload over a relatively short time period show a decrease in ECA rate above these limits. Renshaw AA, et al. Diagn Cytopathol2010 Oct 13 Elsheikh T, et al. Cancer Cytopathol2010;118: Levi A, et al. Cancer Cytopathol2010;118:307. Discussion: Preliminary ASC Recommendation #4 © 2011 College of American Pathologists. All rights reserved. 11

Recommendation #4: Do you: A.Agree with statement as is32.61% B.Agree with FDA only32.61% C.Agree with 100/day only26.09% D.Disagree with the whole statement 8.70% Voting © 2011 College of American Pathologists. All rights reserved. 12

The percentage of imaged slides that undergo full manual review should be at least either 15%, or twice (2x) the epithelial cell abnormality (ECA) rate, whichever is greater. o Recommendation based on survey data presented at the 2009 ASC Annual Scientific meeting. The majority of laboratories manually review at least 15% of cases. Miller FN. What is a Reasonable and Realistic Workload Limit in the Age of Image-Assisted Pap Testing? ASC Annual Scientific Meeting, Nov 16, 2009 Discussion: Preliminary ASC Recommendation #5 © 2011 College of American Pathologists. All rights reserved. 13

Recommendation #5: The percentage of imaged slides that undergo full manual review should be at least either 15%, or twice (2x) the epithelial cell abnormality (ECA) rate, whichever is greater. 65.Do you agree with recommendation #5? A.Yes72.41 B.No22.41% C.Other5.17% Voting © 2011 College of American Pathologists. All rights reserved. 14

The Epithelial Cell Abnormality (ECA)-adjusted workload measure is a promising new method for calculating and monitoring cytotechnologist workload, and can be correlated to desired laboratory screening sensitivity. This method may be especially useful in the setting of higher ECA rates. Further studies of this method are encouraged before full endorsement of this method, by this task force, is issued. o ECA-adjusted workload is the only measure that has been directly correlated with screening sensitivity. o ECA-adjusted workload has been shown to directly correlate with screening sensitivity at the level of ASCUS, LSIL, and HSIL in the FDA TIS trial and when comparing manual and automated screening to assess the workload cut off in Recommendation #4 Renshaw AA, Elsheikh TM. Diagn Cytopathol2010 Nov 22. Renshaw AA, et al. Diagn Cytopathol2010 Oct 13 Elsheikh T, et al. Cancer Cytopathol2010;118: Levi A, et al. Cancer Cytopathol2010;118:307. Discussion: Preliminary ASC Recommendation #6 © 2011 College of American Pathologists. All rights reserved. 15

66.Should the ECA adjusted workload measure be further investigated A.Yes87.27% B.No12.73% Voting © 2011 College of American Pathologists. All rights reserved. 16

Cytotechnologist productivity and workload limits are just one aspect of a good quality assurance program in a cytology laboratory. Other quality indicators to assess cytotechnologist performance (screening not interpretation) should be implemented. The other quality indicators, many of which of will be discussed and voted on today, are also important components in determining screening limits. Discussion: Preliminary ASC Recommendation #7 © 2011 College of American Pathologists. All rights reserved. 17

Although there are studies documenting the utility of the recommended measures for general QA, few correlate them with screening sensitivity No current studies correlate these QA measures with workload. Renshaw AA, et al. Diagn Cytopathol2010(38): Renshaw AA, et al. Cytojournal2009;6:19 Discussion: Preliminary ASC Recommendation #7 © 2011 College of American Pathologists. All rights reserved. 18

67.Should QA and workload correlation be further investigated? A.Yes94.55% B.No 5.45% Voting © 2011 College of American Pathologists. All rights reserved. 19

Anecdotal evidence suggests that most cytotechnologists cannot achieve adequate sensitivity at workloads set at the upper limit of the CLIA workload limit. Many of the suggested recommendations for imaged-guided workload are also appropriate for manual screening: o Recommendation #1 o Recommendation #2 o Recommendation #3 o Recommendation #6 o Recommendation #7 In addition Renshaw AA, et al. Diagn Cytopathol 2010 Nov 22 Discussion: Additional recommendations for manual workload © 2011 College of American Pathologists. All rights reserved. 20